CND Life Sciences, Inc.
CND Life Sciences, Inc. is a synucleinopathy Diagnostic founded in 2017.
4
Funding Rounds
$14.9m
Money raised
Overview
CND Life Sciences, Inc. is a synucleinopathy Diagnostic founded in 2017.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company CND Life Sciences, Inc. has raised a total of $12.4m in funding over 4 rounds.
Key Insights:
- CND Life Sciences, Inc. Seed round, February 2022: $5m
- CND Life Sciences, Inc. Funding Round, November 2021: $5m
- CND Life Sciences, Inc. Seed round, March 2021: $2.4m
- CND Life Sciences, Inc. funding round, January 2021: $2.5m
CND Life Sciences, Inc. Seed round, February 2022
$5m
CND Life Sciences, Inc. Funding Round, November 2021
$5m
CND Life Sciences, Inc. Seed round, March 2021
$2.4m
CND Life Sciences, Inc. funding round, January 2021
$2.5m
Industries
CND Life Sciences, Inc. is active in the following industries: